Page last updated: 2024-08-17

cordycepin and Granulocytic Leukemia, Chronic

cordycepin has been researched along with Granulocytic Leukemia, Chronic in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, X; Gao, XY; Liu, J; Liu, Y; Tian, YY; Wang, JH; Wang, Y; Xu, P; Xue, YM; Zhang, XM1
Constantinou, A; Grdina, D; Huberman, E; Kiguchi, K1

Other Studies

2 other study(ies) available for cordycepin and Granulocytic Leukemia, Chronic

ArticleYear
Synergistic effect of HMGB1 knockdown and cordycepin in the K562 human chronic myeloid leukemia cell line.
    Molecular medicine reports, 2015, Volume: 12, Issue:3

    Topics: Antineoplastic Agents; Apoptosis; Cell Adhesion; Cell Proliferation; Combined Modality Therapy; Cyclooxygenase 2; Deoxyadenosines; Gene Knockdown Techniques; HEK293 Cells; HMGB1 Protein; Humans; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Reactive Oxygen Species; Receptor for Advanced Glycation End Products; RNA, Small Interfering

2015
The effect of topoisomerase inhibitors on the expression of differentiation markers and cell cycle progression in human K-562 leukemia cells.
    Experimental cell research, 1992, Volume: 203, Issue:1

    Topics: Amsacrine; Aphidicolin; Cell Cycle; Cell Differentiation; Cycloheximide; Deoxyadenosines; Dose-Response Relationship, Drug; Etoposide; G2 Phase; Hemoglobins; Humans; Kinetics; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Melanins; Mitosis; Novobiocin; Teniposide; Topoisomerase II Inhibitors; Tumor Cells, Cultured

1992